Drugs / fRPE cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02868424 | Feb 2016 → Aug 2018 | age-related macular degeneration | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fRPE cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02868424 ↗ |
| Modality | Cell therapy | “Human fetal Retinal Pigment Epithelial(fRPE) Cells Subretinal Transplantation” NCT02868424 ↗ |
| Route | Other | “administered into the subretinal space of experimental eye through a standard surgical approach” NCT02868424 ↗ |